Morgan Stanley upgraded Emerson Electric (EMR) to Overweight from Equal Weight with a price target of $96, up from $95. The stock’s risk/reward is among the best in the sector with the National Instruments (NATI) resolution potentially being a "win-win as management lands an accretive deal or establishes its discipline," the analyst tells investors in a research note. The firm says Emerson’s fundamentals are accelerating, particularly with liquified natural gas and hydrogen. It sees an attractive risk/reward at current share levels.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on EMR:
- Emerson Electric selected to automate photovoltaic project in New Zealand
- Emerson selected to automate Golden Triangle Polymers facility
- Emerson Electric upgraded to Buy from Neutral at UBS
- Emerson Electric price target lowered to $105 from $115 at Cowen
- Argus cuts Emerson Electric to Hold, sees ‘problematic’ recent trends